Skip to main content
Shelly Lu, MD, Gastroenterology, Los Angeles, CA

ShellyLuMD

Gastroenterology Los Angeles, CA

Director, Karsh Division of Gastroenterology and Hepatology; Vice Chair of Basic and Translational Research; Professor of Medicine, Cedars-Sinai Medical Center; Professor of Medicine Step 7, UCLA; Adjunct Professor of Medicine, Keck School of Medicine USC

Dr. Lu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Lu's full profile

Already have an account?

  • Office

    1520 San Pablo St
    Ste 1000
    Los Angeles, CA 90033
    Phone+1 323-442-5100

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 1985 - 1988
  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterResidency, Internal Medicine, 1982 - 1985
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 1982
  • University of California, Los Angeles
    University of California, Los AngelesBA, Biology, Highest Honors in Biology and Summa Cum Laude, 1974 - 1978

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1983 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • Prize for Research in Scientific Medicine (PRISM) Award Cedars-Sinai Medical Center, 2021
  • Mayo Soley Award for Lifetime Achievement in Science and Mentoring Western Society of Clinical Investigation, 2012
  • Outstanding Women in Science American Gastroenterological Association, 2008
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications for Liver Transplant and Ethnic and Gender Variances  
    Tsuyoshi Todo, Walid S Ayoub, Naim Alkhouri, Nicholas N Nissen, Vinay Sundaram, Shelly C Lu, Mazen Noureddin, Aarshi Vipani, Tram Tran, Andrew S Klein, Nature
  • Sex and racial/ethnic differences in the association of obesity with risk of hepatocellular carcinoma  
    Setiawan VW, Lim U, Lipworth L, Lu SC, Shepherd J, Ernst T, Henderson BE, Le Marchand L, Clin Gastroenterology Hepatol, 1/1/2016
  • Methionine and S-adenosylmethionine levels are critical regulators of PP2A activity modulating lipophagy during steatosis  
    Zubiete-Franco I, García-Rodríguez JL, Martínez-Uña M, Matínez-Lopez N, Woodhoo A, Gutiérrez-De JV, Beraza N, Lage-Medina S, Andrade F, Fernandez ML, Aldámiz-Echevarrí..., J Hepatol, 1/1/2016
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Metabolomic classification of murine and human nonalcoholic fatty liver disease
    Alonso C, Lavin JL, Iruarrizaga-Lejarreta M, Fernández-Ramos D, van-Liempd S, delaCruz-Villar L, Navasa N, Martínez-Arranz I, Aurrekoetxea I, Buqué X, Varela M, Falcón..., Hepatology, 1/1/2016
  • Prohibitin 1 represses c-Myc-driven E-box gene expression and acts as a tumor suppressor in liver cancers in mice and humans
    Fan W, Yang HP, Wang J, Li TWH, Alagappan A, Mato JM, Lu SC, Hepatology, 1/1/2016
  • Prohibitin-1 regulates cellular proliferation by controlling the H19-Igf2 axis in the liver
    Ramani K, Mavila N, Lu SC, Hepatology, 1/1/2016
  • Join now to see all

Press Mentions

  • How Gravity May Cause Irritable Bowel Syndrome
    How Gravity May Cause Irritable Bowel SyndromeDecember 1st, 2022
  • Tipsheet: Cedars-Sinai Experts Share Research, Healthcare Innovations at Digestive Disease Week 2022
    Tipsheet: Cedars-Sinai Experts Share Research, Healthcare Innovations at Digestive Disease Week 2022May 18th, 2022
  • Cedars-Sinai Gets $9.1 Million Federal Grant for Liver Cancer Study
    Cedars-Sinai Gets $9.1 Million Federal Grant for Liver Cancer StudyFebruary 6th, 2020
  • Join now to see all

Grant Support

  • S-Adenosylmethionine in protein posttranslational modifications and HCC treatmentNIH2015–2019
  • Role of SAMe in pathogenesis and treatment of non-alcoholic fatty liver diseaseNIH2014–2019
  • Prohibitin 1 in Liver Injury and CancerNIH2014–2018
  • Dysregulation of GSH Synthesis During Liver Injury and FibrosisNIH2012–2018
  • Regulation and functions of methionine adenosyltransferase genes in liverNIH2011–2017
  • Role Of MAT And SAME In Colon Cancer Pathogenesis And TreatmentNational Center For Complementary &Alternative Medicine2008–2011
  • Role Of SAME In Liver Function And InjuryNational Center For Complementary &Alternative Medicine2002–2011
  • Regulation Of Hepatic Glutathione SynthesisNational Institute Of Diabetes And Digestive And Kidney Diseases2010
  • Regulation Of Methionine Adenosyltransferase In LiverNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2010
  • Core-- Cell CultureNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2009
  • Regulation Of Hepatic Glutathione SynthesisNational Institute Of Diabetes And Digestive And Kidney Diseases1997–2008
  • MAT1A NULL Mouse: Model For Alcoholic Tissue InjuryNational Institute On Alcohol Abuse And Alcoholism2003–2007
  • Altered Methionine Metabolism In Alcoholic Liver InjuryNational Institute On Alcohol Abuse And Alcoholism2001–2005
  • Core--Cell CultureNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2002
  • Regulation Of S-Adenosylmethionine Synthetase In LiverNational Institute Of Diabetes And Digestive And Kidney Diseases1997–2000
  • Regulation Of Hepatic Glutahione SynthesisNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1996
  • Regulation Of Hepatic Glutathione TurnoverNational Center For Research Resources1990–1991

Other Languages

  • Chinese (Mandarin)